Ameriprise
BNR

Ameriprise’s Burning Rock Biotech BNR Stock Holding History

Ameriprise’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,616
Closed -$1.77M – 3943
2021
Q4 		$1.77M Sell
18,616
-70,547
-79% -$9.66M ﹤0.01% 2995
2021
Q3 		$15.9M Buy
89,163
+3,437
+4% +$764K 0.01% 1459
2021
Q2 		$25.2M Buy
85,726
+4,354
+5% +$1.29M 0.01% 1180
2021
Q1 		$21.9M Buy
81,372
+3,648
+5% +$1.11M 0.01% 1252
2020
Q4 		$18M Buy
77,724
+5,328
+7% +$1.43M 0.01% 1301
2020
Q3 		$18.1M Buy
72,396
+50,185
+226% +$11.9M 0.01% 1136
2020
Q2 		$6M Buy
+22,211
New +$6.09M ﹤0.01% 1930

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise's BNR Position: Q1 2022 in Review

Ameriprise sold out of Burning Rock Biotech (BNR) in Q1 2022, closing a stake of 18,616 shares — an estimated $1.77M sold.

Ameriprise first reported a position in BNR in Q2 2020 and held it in 7 quarters. The position peaked at $25.2M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

  • Ameriprise reported no remaining Burning Rock Biotech position as of Q1 2022 after selling out during the quarter.
  • Ameriprise sold 18,616 Burning Rock Biotech shares in Q1 2022, an estimated $1.77M.
  • Ameriprise first reported a position in Burning Rock Biotech in Q2 2020 and held it in 7 quarters.
  • Ameriprise's Burning Rock Biotech position peaked at $25.2M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.